市場調查報告書
商品編碼
1483138
動物殺寄生蟲劑市場評估:依寄生蟲類型、動物類型、藥物類型、最終用戶和地區劃分的機會和預測(2017-2031)Animal Parasite Treatment Market Assessment, By Parasite Type, By Animal Type, By Treatment Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球獸用寄生蟲劑市場規模將從2023年的102.7億美元成長到2031年的168.1億美元,預計2024-2031年期間複合年增長率為6.35%。
各種體內寄生蟲和體外寄生蟲的威脅日益增加,以及人們對治療解決方案的認識不斷提高,正在推動全球動物殺蟲劑市場的發展。內部和外部寄生蟲都會削弱免疫系統並引起疾病。因此,對各種處理解決方案的需求不斷增加,以確保消除寄生威脅。此外,由於動物產品的高營養價值,世界不同地區對動物產品的消費不斷增加,也推動了對動物寄生蟲解決方案的需求。牛肉和雞肉等非素食成分含有 B 群維生素、蛋白質、鋅、鎂和鐵,這對於確保骨骼、軟骨和肌肉的強度以及荷爾蒙和酵素的最佳產生至關重要。
此外,成功的收購也推動了市場成長。收購使公司能夠透過豐富產品組合併獲得服務更廣泛客戶群的能力來擴大客戶群。2021 年 11 月,NEOGEN Corporation宣佈收購以提供多種寵物藥品而聞名的 CAPInnoVet, Inc.。此次收購擴大了 Neogen 的能力,並使其能夠策略性地進入殺寄生蟲劑市場。
寵物擁有量的增加推動了全球動物殺蟲劑市場:
寵物數量的增加是全球動物殺蟲劑市場的主要趨勢之一。由於城市化的進步和核心家庭的趨勢,人們越來越喜歡飼養寵物。《Forbes》估計,過去幾年美國的寵物擁有量大幅增加,預計到 2024 年,美國約有 66% 的家庭將擁有寵物。人們對各種治療解決方案的可用性的認識不斷提高,以及保護伴侶動物免受痛苦和疾病的願望不斷增強,正在促使寵物主人購買各種獸用殺蟲劑。此外,不需要頻繁給藥的治療方法的開發也推動了市場的擴張,因為此類治療方法因其便利性而受到越來越多的青睞。
該報告調查了全球動物寄生蟲殺劑市場,並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。
Global animal parasite treatment market is projected to witness a CAGR of 6.35% during the forecast period 2024-2031, growing from USD 10.27 billion in 2023 to USD 16.81 billion in 2031F. The growth of the market is boosted by increasing consumption of animal derived products, rising popularity of pet adoption, and novel product launches and strategic collaborations.
The growing threat of various endoparasites and ectoparasites and increasing awareness about the treatment solutions drive the global animal parasite treatment market. Both internal and external parasites can weaken the immune system and cause diseases. Thus augmenting the requirement for different treatment solutions in order to ensure that the threat of parasites can be contained. Additionally, the growing consumption of animal-based products in various regions across the globe due to their high nutritional value is also increasing the demand for animal parasite treatment solutions. Non-vegetarian sources of foods such as beef and poultry include vitamin B, protein, zinc, magnesium, and iron, which are essential for ensuring the strength of bones, cartilage, and muscles and ensuring optimal production of hormones and enzymes.
Additionally, successful acquisitions are also bolstering the growth of the market as they allow companies to enhance their product portfolios and expand their customer base by gaining the ability to cater to a broad clientele. In November 2021, NEOGEN Corporation announced the acquisition of CAPInnoVet, Inc. a company known for providing various pet medications. The transaction expanded NEOGEN's capabilities and allowed them to enter the parasiticide market strategically.
Increasing Pet Adoption is Driving the Global Treatment Market for Animal Parasite
The rise of pet adoption is one of the major global animal parasite treatment market trends. The increasing preference for pet adoption can be attributed to increasing urbanization and the growing popularity of nuclear households. Pet parents have a vested interest in the health and well-being of their pets and ensure that the pets are provided with high-quality care and treatments. As per the estimates of Forbes, pet ownership in the United States has significantly increased over the past few years, and it is estimated that in 2024, approximately 66% of the households in the country own a pet. The growing awareness about the availability of various treatment solutions, coupled with the increasing preference for protecting companion animals from distress and diseases, is encouraging pet owners to spend on various animal parasite treatments. Additionally, the development of treatments that do not require frequent administration is also driving the expansion of the market as preference for such treatment options is increasing due to their convenience.
Introduction of Novel Products is Boosting Global Animal Parasite Treatment Market Demand
The growing emphasis on novel product development and launches is one of the major drivers of the market. In 2022, Vetoquinol launched Felpreva, the first spot-on parasiticide for felines that is capable of treating both external and internal parasite infections and infestations. The three-month spot-on parasiticide belongs to the bispyrazole chemical family and is effective against mites, fleas, and ticks as well as hookworms, lungworms, and roundworms. Meanwhile, in April 2024, Boehringer Ingelheim, one of the global leaders in animal health, announced that they are launching NexGard SPECTRA (milbemycin oxime and afoxolaner) in India. The new flavorful product launched by the company offers a broad spectrum of ecto- and endo-parasite control. This prescription-only product provides comprehensive protection with the help of a single monthly chewable, reducing the burden of treatment on animal owners and caretakers. Such developments and product launches increase the convenience of the care providers and allow companies to expand their customer base, boosting market growth.
North America Holds Significant Share in the Global Animal Parasite Treatment Market
The growth of the market in North America can be attributed to the strong presence of various key market players, the rise of pet adoption in the United States of America and Canada and increasing awareness about the various parasites and their treatments. The rising adoption of companion animals in the region can be attributed to the growing awareness about the various emotional benefits provided by them. The growing adoption of companion animals is supported by a rise in mental health conditions. The Progressive Animal Welfare Services (PAWS) estimates that one in five Canadians live with some form of mental illness. The Mental Health Commission of Canada estimates that approximately 23% of the country's population will be suffering from some mental illness by 2041. Several studies show a strong correlation between adopting a pet and improved mental health, with many emphasizing the mental health benefits of pet ownership. Pets, such as dogs and cats, provide companionship, unconditional love, and emotional support, which can alleviate feelings of loneliness, reduce stress, and boost mood.
Ectoparasiticides Are Expected to Witness Increase in Demand
The rising threat of ticks, mites, and fleas is boosting the demand for ectoparasiticides globally. Ectoparasites affect the skin of animals and can impact the production of animal products such as wool, silk, leather, and many others. The usage of ectoparasiticides is regulated by various governing bodies in different countries. In the United States, the use of ectoparasiticides is regulated by EPA (Environmental Protection Agency). Pour-ons are considered to be more effective against lice infestations (Haematopinus and Linognathus) as compared to equivalent compounds that are administered parenterally. This large consumption of animal-based products, including milk and meat, in various regions across the globe due to the various nutritional benefits offered by the food substances is augmenting the utilization of ectoparasiticides by cattle owners.
Future Market Scenario (2024-2031F)
As per the global animal parasite treatment market analysis, the market demand is expected to witness a significant increase owing to the rise in pet adoption, growing awareness about the various parasite treatment options and their preventive measures, increasing requirement for eco-friendly treatment options, and increasing collaborations to support novel product development. The requirement for treatment solutions that offer efficacy for longer periods of time is expected to rise as they aid in reducing the burden of treatment on livestock and pet owners. Additionally, due to the growing threat of climate change, a shift in preference for eco-friendly solutions is being witnessed across various industries, including animal parasite treatments. Thus, efforts towards the development of eco-friendly treatment solutions are increasing. Partnerships between various organizations are expected to boost such developments. For instance, the partnership between the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and Boehringer Ingelheim is expected to bolster the development of parasiticides.
Key Players Landscape and Outlook
Some of the leading players operating in the global animal parasite treatment market are Bayer AG, Zoetis Inc., Virbac Group, Merck & Co., Inc., and Elanco Animal Health Incorporated. The increasing efforts by various market players towards the development and launch of novel products are providing lucrative growth opportunities to the market. In 2023, Zoetis Inc. introduced the Valcor injectable, the first dual-active endectocide that will be available by prescription in the United States. The product received approval for use in replacement dairy heifers that are younger than twenty months and in beef cattle that are two months and older. The product has been designed to address 35 external and internal parasites. Valcor is also indicated for treating and controlling eyeworms and lungworms, among others, and contains two active ingredients that are responsible for causing parasite paralysis and death. Levamisole stimulates worm muscles, whereas Doramectin modulates chloride ion channel activities in the nervous system of orthopods and nematodes by inhibiting the electrical activity of nerve cells. The development of such products is expected to aid the market players in expanding their customer base and provide lucrative growth opportunities to the market in the forecast period.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work